Working... Menu

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02316197
Recruitment Status : Completed
First Posted : December 12, 2014
Last Update Posted : April 13, 2018
Information provided by (Responsible Party):
Merck KGaA, Darmstadt, Germany

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 29, 2017
  Actual Study Completion Date : June 29, 2017